Though the mechanisms through which this drug might influence alcohol craving and consumption are not known, in theory semaglutides inhibition of the appetitive centers in the brain could lead to reduced cravings and appetite for things other than food, like alcohol and other drugs
Patients with mild to moderate renal impairment generally do not require dose adjustment, but closer monitoring may be warranted, particularly for signs of gastrointestinal adverse effects that could lead to dehydration and worsening renal function
The researchers analyzed electronic health record data from more than 98 healthcare organizations, covering nearly two decades of treatment patterns
Lipo C injections are similarly unlicensed, and neither treatment is recommended or funded by NICE or the NHS
found that GLP-1RAs did not significantly reduce asthma exacerbations, whereas, SGLT-2 inhibitors (SGLT-2i) were associated with a reduced risk of asthma compared to both GLP-1RAs and DPP-4 inhibitors (DPP-4i) [101]